α‐Mangostin Attenuates Blood Pressure and Reverses Vascular Remodeling by Balancing ACE / AT1R and ACE2 /Ang‐(1–7)/ MasR Axes in Ang II ‐Infused Hypertensive Mice
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8353 ↗At a glance
Journal article in Phytotherapy Research, 2024. Written by Qi-Qi Xue and 4 co-authors. Institution: Department of Cardiovascular Medicine, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, National Research Centre for Tran…. Major MEDLINE topics: Xanthones, Angiotensin II, Hypertension, Mice, Inbred C57BL. Cited 9 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China, Shanghai Commission of Science and Technology, Natural Science Foundation of Shanghai Municipality.
Abstract (original language)
Hyperuricemia is a common comorbidity of hypertension and probably has a causal relationship with hypertension. Alpha‐mangostin (α‐MG) has been reported to have uric acid lowering effect. This study aimed to investigate the dual effects of α‐MG on blood pressure (BP) and uric acid levels in angiotensin II (Ang II)‐infused hypertensive mice. Male C57BL/6 mice were randomized into five groups: control, Ang II infusion (500 ng/kg/min for 2 weeks), Ang II infusion with gavage administration of α‐MG 4.0 and 8.0 mg/kg and benzbromarone (25 mg/kg) respectively. BP, uric acid levels, vascular structure and function, and renin–Ang II system expressions in the aorta were assessed. Treatment with α‐MG reduced BP, improved endothelial relaxation, and reversed aortic wall thickening and collagen deposition in Ang II‐induced hypertensive mice. It also downregulated Ang II receptor 1 (AT1R) and angiotensin converting enzyme (ACE) expression, while upregulating ACE2, Mas receptor (MasR), and angiotensin (1–7) in the aorta. Moreover, α‐MG demonstrated a significant enhancement in uric acid clearance and reduction in serum uric acid levels. Conversely, benzbromarone did not result in a decrease in BP, indicating that the hypotensive effect of α‐MG may not be necessarily dependent on its urate‐lowering properties. α‐MG can attenuate Ang II‐induced hypertension and reverse vascular remodeling, potentially by balancing the ACE/Ang II/AT1R axis and the ACE2/Ang‐(1–7)/MasR axis. Our findings provide insights into α‐MG as a novel anti‐hypertensive drug especially in patients with hyperuricemia.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Cardiovascular Medicine, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiatong University Schoo…
ORCID profiles: Qi-Qi Xue
Funding
- National Natural Science Foundation of China
- Shanghai Commission of Science and Technology
- Natural Science Foundation of Shanghai Municipality
- Shanghai Commission of Health
Cite
APA
Xue, Q. Q., Liu, C. H., Zhang, D. Y., Li, M. X., & Li, Y. (2024). α‐Mangostin Attenuates Blood Pressure and Reverses Vascular Remodeling by Balancing ACE / AT1R and ACE2 /Ang‐(1–7)/ MasR Axes in Ang II ‐Infused Hypertensive Mice. Phytotherapy Research. https://doi.org/10.1002/ptr.8353
Vancouver
Xue QQ, Liu CH, Zhang DY, Li MX, Li Y. α‐Mangostin Attenuates Blood Pressure and Reverses Vascular Remodeling by Balancing ACE / AT1R and ACE2 /Ang‐(1–7)/ MasR Axes in Ang II ‐Infused Hypertensive Mice. Phytotherapy Research. 2024. doi:10.1002/ptr.8353
BibTeX
@article{Xue2024,
author = {Xue, Qi-Qi and Liu, Chu-Hao and Zhang, Dong-Yan and Li, Ming-Xuan and Li, Yan},
title = {α‐Mangostin Attenuates Blood Pressure and Reverses Vascular Remodeling by Balancing ACE / AT1R and ACE2 /Ang‐(1–7)/ MasR Axes in Ang II ‐Infused Hypertensive Mice},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8353}
}
EUVIMED